OX118
/ Oxion Biologics
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
May 14, 2026
SAPIOX: A FIRST-IN-HUMAN PHASE I TRIAL OF OX118 IN HEALTHY VOLUNTEERS
(clinicaltrialsregister.eu)
- P1 | N=32 | Completed | Sponsor: Oxion Biologics AB | Recruiting ➔ Completed
First-in-human • Trial completion
June 13, 2025
A First-in-Human Phase I Trial of OX118 in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=32 | Recruiting | Sponsor: Oxion Biologics AB
New P1 trial
1 to 2
Of
2
Go to page
1